Integrative metabolomic and proteomic analysis of diabetic kidney disease progression with younger‐onset type 2 diabetes
Diabetes, Obesity and Metabolism · 2025-12 · 27 (12) · 7454-7463
DOI: 10.1111/dom.70153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 18.09.2025. Verfasst von Resham Lal Gurung und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Singapore. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Nephropathies. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Medical Research Council, Alexandra Health Systems.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
Younger‐onset type 2 diabetes (YT2D) confers a disproportionately high risk of diabetic kidney disease (DKD), yet early biomarkers and underlying mechanisms remain poorly defined. We aimed to identify metabolites associated with DKD progression and integrate metabolomic and proteomic data to elucidate pathways involved in a multi‐ethnic Asian cohort. Materials and Methods In this prospective study, 787 YT2D patients (diagnosed at ≤ age 40) were followed for a median of 5.7 years. DKD progression was defined as an annual decline in estimated glomerular filtration rate (eGFR) of ≥3 mL/min/1.73 m 2 or ≥ 40% reduction in eGFR from baseline. Plasma metabolites were measured by nuclear magnetic resonance spectroscopy. Multivariable regression analysis was performed in a discovery ( N = 550) and internal validation cohort ( N = 237). Integrative metabolomic‐proteomic analysis ( N = 428) was performed using sparse partial least squares discriminant analysis (sPLS‐DA).
Results
Ninety‐eight metabolites were differentially expressed between DKD progressors and non‐progressors, of which total branched‐chain amino acids (BCAAs) (OR = 0.60, 95% CI 0.46–0.79), valine (OR = 0.62, 95% CI 0.48–0.81), and leucine (OR = 0.56, 95% CI 0.43–0.74) associated with DKD progression, independent of metabolic risk factors. Integrative analysis identified three components comprising 23 proteins and 30 metabolites, involved in the citrate cycle and apoptosis, which improved prediction of DKD progression beyond clinical risk factors (AUC 0.69–0.83).
Conclusion
Lower plasma BCAA levels are independently associated with DKD progression in YT2D. Integrative multi‐omics analysis highlights disruptions in metabolic and apoptotic pathways, providing insights into DKD pathophysiology and potential biomarkers for early risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Singapore.
- Cardiovascular and Metabolic Disorders Signature Research Program, Duke-NUS Medical School, Singapore, Singapore.
- Diabetes Centre, Admiralty Medical Centre, Singapore, Singapore.
- Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
ORCID-Profile: Jian-Jun Liu, Su Chi Lim
Förderung
- National Medical Research Council
- Alexandra Health Systems
Zitieren
APA
Gurung, R. L., Zheng, H., Tan, J. L. I., Liu, S., Chan, C., Ang, K., Tan, C., Liu, J. J., Subramaniam, T., Sum, C. F., & Lim, S. C. (2025). Integrative metabolomic and proteomic analysis of diabetic kidney disease progression with younger‐onset type 2 diabetes. Diabetes, Obesity and Metabolism, 27(12), 7454-7463. https://doi.org/10.1111/dom.70153
Vancouver
Gurung RL, Zheng H, Tan JLI, Liu S, Chan C, Ang K, et al. Integrative metabolomic and proteomic analysis of diabetic kidney disease progression with younger‐onset type 2 diabetes. Diabetes, Obesity and Metabolism. 2025;27(12):7454-7463. doi:10.1111/dom.70153
BibTeX
@article{Gurung2025,
author = {Gurung, Resham Lal and Zheng, Huili and Tan, Jia Le Ivan and Liu, Sylvia and Chan, Clara and Ang, Keven and Tan, Clara and Liu, Jian-Jun and Subramaniam, Tavintharan and Sum, Chee Fang and Lim, Su Chi},
title = {Integrative metabolomic and proteomic analysis of diabetic kidney disease progression with younger‐onset type 2 diabetes},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
volume = {27},
number = {12},
pages = {7454--7463},
doi = {10.1111/dom.70153}
}
EUVIMED